company 617 words
Contents

Dopamine Transporter Modulators for Parkinson's Disease

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

CrunchbaseWikipedia

Related Hypotheses (109)

Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
...
Score: 0.68
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.67
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Complement C1q Subtype Switching
Score: 0.66
RNA Granule Nucleation Site Modulation
Score: 0.66
Mitochondrial RNA Granule Rescue Pathway
Score: 0.66
Microbial Inflammasome Priming Prevention
Score: 0.65
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.65
APOE-Mediated Synaptic Lipid Raft Stabilization
Score: 0.65
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.65
Synthetic Biology Rewiring via Orthogonal Receptors
Score: 0.65
Transglutaminase-2 Cross-Linking Inhibition Strategy
Score: 0.64
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.63
← Prevpg 4/6Next →

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

See Also (13)

Striatum
brain · KG edge: expressed_in
Parkinson Basal Ganglia Circuit
circuit · KG edge: loss_affects
NeuRon Therapeutics
company · KG edge: loss_affects
Neurodegeneration
disease · KG edge: loss_affects
acetylcholine
general · KG edge: co_discussed

Knowledge Graph (8 edges)

Neuroinflammatory Priming associated_with Dopaminergic Neurodegeneration
neuroinflammation causes Dopaminergic neuron vulnerability
substantia_nigra decreases_risk Dopaminergic Neuron Loss
Dopamine Biosynthesis associated_with Parkinson's Disease
NEURON associated_with Dopaminergic
PARKINSON associated_with Dopaminergic
ASTROCYTES associated_with Dopaminergic
MICROGLIA associated_with Dopaminergic

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.